BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1095 related articles for article (PubMed ID: 10363194)

  • 1. Helicobacter pylori increases the risk of peptic ulcer bleeding: a case-control study.
    Labenz J; Peitz U; Köhl H; Kaiser J; Malfertheiner P; Hackelsberger A; Börsch G
    Ital J Gastroenterol Hepatol; 1999 Mar; 31(2):110-5. PubMed ID: 10363194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of helicobacter pylori infection on the risk of upper gastrointestinal bleeding in users of nonsteroidal anti-inflammatory drugs.
    Papatheodoridis GV; Papadelli D; Cholongitas E; Vassilopoulos D; Mentis A; Hadziyannis SJ
    Am J Med; 2004 May; 116(9):601-5. PubMed ID: 15093756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in the prevalence of peptic ulcer disease and Helicobacter pylori infection in family physician-referred uninvestigated dyspeptic patients in Hong Kong.
    Xia B; Xia HH; Ma CW; Wong KW; Fung FM; Hui CK; Chan CK; Chan AO; Lai KC; Yuen MF; Wong BC
    Aliment Pharmacol Ther; 2005 Aug; 22(3):243-9. PubMed ID: 16091062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Helicobacter pylori and perforated peptic ulcer prevalence of the infection and role of non-steroidal anti-inflammatory drugs.
    Gisbert JP; Legido J; García-Sanz I; Pajares JM
    Dig Liver Dis; 2004 Feb; 36(2):116-20. PubMed ID: 15002818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the risk factors and their combinations in acute gastroduodenal ulcer bleeding: a case-control study.
    Udd M; Miettinen P; Palmu A; Heikkinen M; Janatuinen E; Pasanen P; Tarvainen R; Mustonen H; Julkunen R
    Scand J Gastroenterol; 2007 Dec; 42(12):1395-403. PubMed ID: 17994466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specifics of Helicobacter pylori infection/NSAID effects in the elderly.
    Davidovic M; Svorcan P; Milanovic P; Antovic A; Milosevic D
    Rom J Gastroenterol; 2005 Sep; 14(3):253-8. PubMed ID: 16200236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of peptic ulcer bleeding associated with Helicobacter pylori infection, nonsteroidal anti-inflammatory drugs, low-dose aspirin, and antihypertensive drugs: a case-control study.
    Nagata N; Niikura R; Sekine K; Sakurai T; Shimbo T; Kishida Y; Tanaka S; Aoki T; Okubo H; Watanabe K; Yokoi C; Akiyama J; Yanase M; Mizokami M; Uemura N
    J Gastroenterol Hepatol; 2015 Feb; 30(2):292-8. PubMed ID: 25339607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Additive deleterious effect of smoking on gastroduodenal pathology and clinical course in Helicobacter pylori-positive dyspeptic patients.
    Moshkowitz M; Brill S; Konikoff FM; Averbuch M; Arber N; Halpern Z
    Isr Med Assoc J; 2000 Dec; 2(12):892-5. PubMed ID: 11344768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is non-Helicobacter pylori, non-NSAID peptic ulcer a common cause of upper GI bleeding? A prospective study of 977 patients.
    Chan HL; Wu JC; Chan FK; Choi CL; Ching JY; Lee YT; Leung WK; Lau JY; Chung SC; Sung JJ
    Gastrointest Endosc; 2001 Apr; 53(4):438-42. PubMed ID: 11275883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effectiveness of (IgG-ELISA) serology as an alternative diagnostic method for detecting Helicobacter pylori infection in patients with gastro-intestinal bleeding due to gastro-duodenal ulcer.
    García-Díaz E; Castro-Fernández M; Romero-Gómez M; Vargas-Romero J
    Rev Esp Enferm Dig; 2002 Dec; 94(12):725-36. PubMed ID: 12733331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for peptic ulcer bleeding in terms of Helicobacter pylori, NSAIDs, and antiplatelet agents.
    Kang JM; Kim N; Lee BH; Park HK; Jo HJ; Shin CM; Lee SH; Park YS; Hwang JH; Kim JW; Jeong SH; Lee DH; Jung HC; Song IS
    Scand J Gastroenterol; 2011 Nov; 46(11):1295-301. PubMed ID: 21815866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Helicobacter pylori-negative peptic ulcer in Japan: which contributes most to peptic ulcer development, Helicobacter pylori, NSAIDS or stress?
    Aoyama N; Shinoda Y; Matsushima Y; Shirasaka D; Kinoshita Y; Kasuga M; Chiba T
    J Gastroenterol; 2000; 35 Suppl 12():33-7. PubMed ID: 10779215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Risk factors for peptic ulcer bleeding].
    Søberg T; Hofstad B; Sandvik L; Johansen M; Lygren I
    Tidsskr Nor Laegeforen; 2010 Jun; 130(11):1135-9. PubMed ID: 20531499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Helicobacter pylori infection does not affect the early rebleeding rate in patients with peptic ulcer bleeding after successful endoscopic hemostasis: a prospective single-center trial.
    Schilling D; Demel A; Nüsse T; Weidmann E; Riemann JF
    Endoscopy; 2003 May; 35(5):393-6. PubMed ID: 12701009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of bleeding peptic ulcers: a prospective study.
    Liu NJ; Lee CS; Tang JH; Cheng HT; Chu YY; Sung KF; Lin CH; Tsou YK; Lien JM; Chen PC; Chiu CT; Cheng CL
    J Gastroenterol Hepatol; 2008 Aug; 23(8 Pt 2):e340-7. PubMed ID: 17944885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Helicobacter pylori eradication may reduce the risk of gastroduodenal lesions in chronic NSAID users.
    Russell RI
    Ital J Gastroenterol Hepatol; 1997 Oct; 29(5):465-9. PubMed ID: 9494858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meta-analysis: role of Helicobacter pylori eradication in the prevention of peptic ulcer in NSAID users.
    Vergara M; Catalán M; Gisbert JP; Calvet X
    Aliment Pharmacol Ther; 2005 Jun; 21(12):1411-8. PubMed ID: 15948807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proton-pump inhibitors reduce the risk of uncomplicated peptic ulcer in elderly either acute or chronic users of aspirin/non-steroidal anti-inflammatory drugs.
    Pilotto A; Franceschi M; Leandro G; Paris F; Cascavilla L; Longo MG; Niro V; Andriulli A; Scarcelli C; Di Mario F
    Aliment Pharmacol Ther; 2004 Nov; 20(10):1091-7. PubMed ID: 15569111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prevalence of peptic ulcer not related to Helicobacter pylori or non-steroidal anti-inflammatory drug use is negligible in southern Europe.
    Arroyo MT; Forne M; de Argila CM; Feu F; Arenas J; de la Vega J; Garrigues V; Mora F; Castro M; Bujanda L; Cosme A; Castiella A; Gisbert JP; Hervas A; Lanas A
    Helicobacter; 2004 Jun; 9(3):249-54. PubMed ID: 15165261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Bleeding peptic ulcer. Prevalence of Helicobacter pylori and use of nonsteroidal anti-inflammatory drugs/acetylsalicylic acid].
    Vestergård A; Bredahl K; de Muckadell OB; Pedersen OB; Hansen JM
    Ugeskr Laeger; 2009 Jan; 171(4):235-9. PubMed ID: 19174039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 55.